Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · IEX Real-Time Price · USD
16.53
+0.58 (3.64%)
At close: Mar 27, 2024, 4:00 PM
16.52
-0.01 (-0.06%)
After-hours: Mar 27, 2024, 6:17 PM EDT

Enanta Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Year 2023202220212020201920182017201620152014 2013 - 2010
Net Income
-133.82-121.76-79-36.1746.3871.9617.7121.6778.9934.44
Upgrade
Depreciation & Amortization
2.372.973.333.643.262.522.141.660.640.35
Upgrade
Share-Based Compensation
28.2226.9720.9919.5819.2315.8512.867.614.022.57
Upgrade
Other Operating Activities
0.087.03-15.3320.042.55-61.119.954.88-6.98-17.18
Upgrade
Operating Cash Flow
-103.15-84.78-707.0971.4229.2252.6535.8176.6720.18
Upgrade
Operating Cash Flow Growth
----90.08%144.41%-44.50%47.04%-53.30%279.96%89.42%
Upgrade
Capital Expenditures
-9.06-2.13-0.75-1.45-5.42-2.98-2.51-4.74-2.34-1.03
Upgrade
Change in Investments
-44.5257.0237.7421.28-81.25-32.42-2.07-38.93-85.691.52
Upgrade
Other Investing Activities
---------0.160
Upgrade
Investing Cash Flow
-53.5854.936.9919.83-86.66-35.4-4.57-43.66-88.190.5
Upgrade
Share Issuance / Repurchase
2.2121.263.6110.486.856.241.081.030.731.05
Upgrade
Debt Issued / Paid
-0.33000-0.09-0.08-0.07-0.0700
Upgrade
Other Financing Activities
196.24-1.23-0.53-1.5-4.19-1.760.011.751.810.11
Upgrade
Financing Cash Flow
198.1320.033.088.982.574.411.022.712.541.16
Upgrade
Net Cash Flow
41.39-9.85-29.9335.9-12.67-1.7749.1-5.15-8.9721.84
Upgrade
Free Cash Flow
-112.21-86.91-70.755.646626.2450.1531.0774.3419.15
Upgrade
Free Cash Flow Growth
----91.45%151.54%-47.68%61.39%-58.20%288.16%90.61%
Upgrade
Free Cash Flow Margin
-141.67%-100.87%-72.88%4.61%32.16%12.70%48.77%35.20%46.21%40.11%
Upgrade
Free Cash Flow Per Share
-5.35-4.22-3.510.283.371.362.631.643.981.04
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).